Published in J Immunol on February 10, 2010
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Immune regulation by atypical chemokine receptors. Nat Rev Immunol (2013) 1.17
Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood (2011) 1.04
Atypical chemokine receptors. Exp Cell Res (2011) 0.96
Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels. Immunology (2014) 0.90
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol (2012) 0.90
Leukocyte driven-decidual angiogenesis in early pregnancy. Cell Mol Immunol (2014) 0.88
DARC and D6: silent partners in chemokine regulation? Immunol Cell Biol (2010) 0.84
Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor. J Immunol (2013) 0.80
The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens. Immunol Cell Biol (2014) 0.78
The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding. J Biol Chem (2014) 0.77
Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response. Front Immunol (2016) 0.77
Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2. J Invest Dermatol (2016) 0.76
Placental Chemokine Receptor D6 Is Functionally Impaired in Pre-Eclampsia. PLoS One (2016) 0.75
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (2010) 14.24
Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol (2012) 6.91
CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol (2008) 5.35
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet (2008) 4.70
Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation (2010) 4.12
Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ (2002) 3.96
Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med (2004) 3.87
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol (2005) 2.98
Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab (2002) 2.80
BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell (2011) 2.79
Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr (2011) 2.67
SMAUG is a major regulator of maternal mRNA destabilization in Drosophila and its translation is activated by the PAN GU kinase. Dev Cell (2007) 2.64
Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation (2012) 2.54
Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod (2003) 2.47
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med (2007) 2.39
Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 2.38
CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One (2010) 2.28
Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol (2002) 2.24
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum Reprod (2013) 2.23
Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest (2010) 2.19
Gestational-age-specific reference ranges for blood pressure in pregnancy: findings from a prospective cohort. J Hypertens (2015) 2.14
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol (2008) 2.08
Manifestations of chronic disease during pregnancy. JAMA (2005) 2.06
A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One (2011) 1.99
Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab (2006) 1.97
Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension (2004) 1.92
Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol (2005) 1.90
Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res (2002) 1.86
Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension (2012) 1.85
CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J Am Soc Nephrol (2009) 1.79
Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol (2013) 1.75
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest (2012) 1.73
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis (2004) 1.66
Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study. Lancet (2012) 1.63
The potential role of heparin in assisted conception. Hum Reprod Update (2008) 1.62
Maternal adiposity--a determinant of perinatal and offspring outcomes? Nat Rev Endocrinol (2012) 1.62
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol (2008) 1.61
Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology (2009) 1.61
Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension (2003) 1.60
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell (2004) 1.60
Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A (2011) 1.59
The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update (2014) 1.57
ICU nurses' experiences in providing terminal care. Crit Care Nurs Q (2010) 1.55
Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG (2005) 1.55
A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial. BMC Pregnancy Childbirth (2014) 1.55
A critical look at HLA-G. Trends Immunol (2008) 1.55
Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod (2002) 1.54
The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor. Reprod Sci (2009) 1.52
Established preeclampsia risk factors are related to patterns of blood pressure change in normal term pregnancy: findings from the Avon Longitudinal Study of Parents and Children. J Hypertens (2011) 1.50
Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond) (2010) 1.50
Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation (2010) 1.49
A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development (2003) 1.48
Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. Lancet (2002) 1.47
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest (2007) 1.46
A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol (2007) 1.46
Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod (2009) 1.42
Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol (2010) 1.41
Unique receptor repertoire in mouse uterine NK cells. J Immunol (2008) 1.41
Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.39
Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC Genomics (2011) 1.39
Predicting NCLEX success with the HESI Exit Exam: fourth annual validity study. Comput Inform Nurs (2002) 1.38
Decrease new graduate nurse orientation costs by using HESI exit exam scores. J Nurs Adm (2007) 1.38
Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest (2013) 1.36
Prenatal smoking and alterations in newborn heart rate during transition. J Obstet Gynecol Neonatal Nurs (2002) 1.36
Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One (2008) 1.36
Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med (2008) 1.34
Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol (2012) 1.34
Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension (2003) 1.33
Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. Eur Heart J (2011) 1.31
Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol (2004) 1.31
First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes (2010) 1.30
Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol (2008) 1.30
Impact of Scotland's smoke-free legislation on pregnancy complications: retrospective cohort study. PLoS Med (2012) 1.30
Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol (2011) 1.29
Dendritic cells in the human decidua. Biol Reprod (2003) 1.29
Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab (2002) 1.28
Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study. Arterioscler Thromb Vasc Biol (2004) 1.26
Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources. Stem Cells (2007) 1.24
Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest (2014) 1.23
Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets (2004) 1.21